179 related articles for article (PubMed ID: 25238583)
21. Function-Oriented Synthesis: Design, Synthesis, and Evaluation of Highly Simplified Bryostatin Analogues.
Wender PA; Sloane JL; Luu-Nguyen QH; Ogawa Y; Shimizu AJ; Ryckbosch SM; Tyler JH; Hardman C
J Org Chem; 2020 Dec; 85(23):15116-15128. PubMed ID: 33200928
[TBL] [Abstract][Full Text] [Related]
22. Deletion of the C26 Methyl Substituent from the Bryostatin Analogue Merle 23 Has Negligible Impact on Its Biological Profile and Potency.
Zhao X; Kedei N; Michalowski A; Lewin NE; Keck GE; Blumberg PM
Chembiochem; 2018 May; 19(10):1049-1059. PubMed ID: 29517836
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes.
Ryckbosch SM; Wender PA; Pande VS
Nat Commun; 2017 Feb; 8(1):6. PubMed ID: 28232750
[TBL] [Abstract][Full Text] [Related]
24. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
Thangsunan P; Tateing S; Hannongbua S; Suree N
J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
[TBL] [Abstract][Full Text] [Related]
25. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
[TBL] [Abstract][Full Text] [Related]
26. Marine natural products: bryostatins in preclinical and clinical studies.
Kollár P; Rajchard J; Balounová Z; Pazourek J
Pharm Biol; 2014 Feb; 52(2):237-42. PubMed ID: 24033119
[TBL] [Abstract][Full Text] [Related]
27. The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development.
Ruan BF; Zhu HL
Curr Med Chem; 2012; 19(16):2652-64. PubMed ID: 22506770
[TBL] [Abstract][Full Text] [Related]
28. Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.
Wender PA; Dechristopher BA; Schrier AJ
J Am Chem Soc; 2008 May; 130(21):6658-9. PubMed ID: 18452292
[TBL] [Abstract][Full Text] [Related]
29. Role of the C8 gem-dimethyl group of bryostatin 1 on its unique pattern of biological activity.
Keck GE; Poudel YB; Rudra A; Stephens JC; Kedei N; Lewin NE; Blumberg PM
Bioorg Med Chem Lett; 2012 Jun; 22(12):4084-8. PubMed ID: 22579485
[TBL] [Abstract][Full Text] [Related]
30. Total synthesis of bryostatin 16 using a Pd-catalyzed diyne coupling as macrocyclization method and synthesis of C20-epi-bryostatin 7 as a potent anticancer agent.
Trost BM; Dong G
J Am Chem Soc; 2010 Nov; 132(46):16403-16. PubMed ID: 21043491
[TBL] [Abstract][Full Text] [Related]
31. Total synthesis of bryostatin 3.
Trost BM; Wang Y; Buckl AK; Huang Z; Nguyen MH; Kuzmina O
Science; 2020 May; 368(6494):1007-1011. PubMed ID: 32467391
[TBL] [Abstract][Full Text] [Related]
32. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.
Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM
Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896
[TBL] [Abstract][Full Text] [Related]
33. Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation.
Abramson E; Hardman C; Shimizu AJ; Hwang S; Hester LD; Snyder SH; Wender PA; Kim PM; Kornberg MD
Cell Chem Biol; 2021 Apr; 28(4):537-545.e4. PubMed ID: 33472023
[TBL] [Abstract][Full Text] [Related]
34. Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death.
Staveness D; Abdelnabi R; Schrier AJ; Loy BA; Verma VA; DeChristopher BA; Near KE; Neyts J; Delang L; Leyssen P; Wender PA
J Nat Prod; 2016 Apr; 79(4):675-9. PubMed ID: 26900625
[TBL] [Abstract][Full Text] [Related]
35. New approaches to the total synthesis of the bryostatin antitumor macrolides.
Hale KJ; Manaviazar S
Chem Asian J; 2010 Apr; 5(4):704-54. PubMed ID: 20354984
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of seco-B-ring bryostatin analogue WN-1 via C-C bond-forming hydrogenation: critical contribution of the B-ring in determining bryostatin-like and phorbol 12-myristate 13-acetate-like properties.
Andrews IP; Ketcham JM; Blumberg PM; Kedei N; Lewin NE; Peach ML; Krische MJ
J Am Chem Soc; 2014 Sep; 136(38):13209-16. PubMed ID: 25207655
[TBL] [Abstract][Full Text] [Related]
37. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.
DeChristopher BA; Fan AC; Felsher DW; Wender PA
Oncotarget; 2012 Jan; 3(1):58-66. PubMed ID: 22308267
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Chromane-Based Bryostatin Analogues Prepared via Hydrogen-Mediated C-C Bond Formation: Potency Does Not Confer Bryostatin-like Biology.
Ketcham JM; Volchkov I; Chen TY; Blumberg PM; Kedei N; Lewin NE; Krische MJ
J Am Chem Soc; 2016 Oct; 138(40):13415-13423. PubMed ID: 27676096
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin.
Wender PA; Verma VA
Org Lett; 2006 Apr; 8(9):1893-6. PubMed ID: 16623578
[TBL] [Abstract][Full Text] [Related]
40. Total synthesis of bryostatin 16 using atom-economical and chemoselective approaches.
Trost BM; Dong G
Nature; 2008 Nov; 456(7221):485-8. PubMed ID: 19037312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
